Latest Breaking News On - Myriad genetics inc - Page 1 : comparemela.com

Global Anti-Radiation Drugs Market to Register Incremental Growth at a CAGR of ~9% by 2030

/PRNewswire/ DelveInsight s Anti-Radiation Drugs Market Insights report provides the current and forecast market analysis, individual leading anti-radiation.

DelveInsight Business Research, LLP: Global Anti-Radiation Drugs Market to Register Incremental Growth at a CAGR of ~9% by 2030

The rise in demand for anti-radiation drugs is mainly driven by several factors. These include the growing occurrence of side effects linked to cancer screening methods, heightened risks of

Insider Sale: President and CEO Paul Diaz Sells 227,844 Shares of Myriad Genetics Inc (MYGN)

On May 15, 2024, Paul Diaz, President and Chief Executive Officer of Myriad Genetics Inc (NASDAQ:MYGN), executed a significant transaction by selling 227,844 shares of the company.

Insider Sale: Director Lee Newcomer Sells 6,200 Shares of Myriad Genetics Inc (MYGN)

On May 13, 2024, Director Lee Newcomer sold 6,200 shares of Myriad Genetics Inc (NASDAQ:MYGN) as reported in a recent SEC Filing.

Cancer Diagnostics Market size is set to grow by USD 12. 63 Bn from 2023-2027, high prevalence of cancer to boost the market growth, Technavio